Cargando…

Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer

BACKGROUND: Radio-chemotherapy is one of the steps of multidisciplinary management in locally advanced pancreatic cancer. The Epidermal Growth Factor Receptor (EGFR) plays an important role in the disease pathway. The purpose of this prospective study is to evaluate the feasibility and the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fiore, Michele, Trodella, Lucio, Valeri, Sergio, Borzomati, Domenico, Floreno, Barnaba, Ippolito, Edy, Trecca, Pasquale, Trodella, Luca Eolo, D’Angelillo, Rolando Maria, Ramella, Sara, Coppola, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681028/ https://www.ncbi.nlm.nih.gov/pubmed/26670587 http://dx.doi.org/10.1186/s13014-015-0564-8

Ejemplares similares

Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer
por: Fiore, Michele, et al.
Publicado: (2017)

Preventing Cardiotoxicity in Personalized Breast Irradiation
por: Ippolito, Edy, et al.
Publicado: (2023)

Factors Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: The Experience of a Single Institution with 269 Patients (STONE-01)
por: Fiore, Michele, et al.
Publicado: (2021)

Estimation of patient setup uncertainty using BrainLAB Exatrac X‐Ray 6D system in image‐guided radiotherapy
por: Infusino, Erminia, et al.
Publicado: (2015)

Can we prevent COVID-19 from causing victims among uninfected cancer patients?()
por: Ramella, Sara, et al.
Publicado: (2020)

Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system
por: Ippolito, Edy, et al.
Publicado: (2018)

Erlotinib and Concurrent Chemoradiation in Pretreated NSCLC Patients: Radiobiological Basis and Clinical Results
por: Ramella, Sara, et al.
Publicado: (2013)

The psychological impact of the covid-19 pandemic on radiotherapy cancer patients
por: Vicinanza, Flavia, et al.
Publicado: (2022)

COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases()
por: Ippolito, Edy, et al.
Publicado: (2020)

Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial
por: Vincenzi, B, et al.
Publicado: (2006)

PO-1179 Radiation induced pneumonitis during COVID-19: artificial intelligence for differential diagnosis.
por: Ippolito, E., et al.
Publicado: (2021)

Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift
por: Ippolito, Edy, et al.
Publicado: (2022)

In Situ Identification of CD44+/CD24− Cancer Cells in Primary Human Breast Carcinomas
por: Perrone, Giuseppe, et al.
Publicado: (2012)

Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series
por: Ippolito, Edy, et al.
Publicado: (2022)

Radiation-Induced Pneumonitis in the Era of the COVID-19 Pandemic: Artificial Intelligence for Differential Diagnosis
por: Giordano, Francesco Maria, et al.
Publicado: (2021)

Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review
por: Fiore, Michele, et al.
Publicado: (2023)

A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients
por: Ramella, Sara, et al.
Publicado: (2018)

BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients
por: Ippolito, Edy, et al.
Publicado: (2023)

A Bio-Imaging Signature as a Predictor of Clinical Outcomes in Locally Advanced Pancreatic Cancer
por: Fiore, Michele, et al.
Publicado: (2020)

Efficacy of gemcitabine and cetuximab combination treatment in head and neck squamous cell carcinoma
por: MASEKI, SHINICHIRO, et al.
Publicado: (2013)

The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria
por: Bottero, Marta, et al.
Publicado: (2021)

42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis
por: Ramella, S., et al.
Publicado: (2021)

Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study †
por: Ciabattoni, Antonella, et al.
Publicado: (2022)

Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model
por: Zardi, Enrico M, et al.
Publicado: (2007)

Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report
por: Sprinzl, Martin F, et al.
Publicado: (2006)

Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Charalambakis, Nikolaos, et al.
Publicado: (2013)

FK506-binding protein 51 is a possible novel tumoral marker
por: Romano, S, et al.
Publicado: (2010)

Dynomics: A Novel and Promising Approach for Improved Breast Cancer Prognosis Prediction
por: Inglese, Marianna, et al.
Publicado: (2023)

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study
por: Kullmann, F, et al.
Publicado: (2009)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020)

Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial
por: Liermann, Jakob, et al.
Publicado: (2022)

Impact of cetuximab conventional dosing on cetuximab-induced magnesium concentration under haemodialysis in head and neck cancer
por: Thariat, Juliette, et al.
Publicado: (2008)

Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer
por: Klinghammer, Konrad, et al.
Publicado: (2020)

Human Fibroblasts In Vitro Exposed to 2.45 GHz Continuous and Pulsed Wave Signals: Evaluation of Biological Effects with a Multimethodological Approach
por: Regalbuto, Elisa, et al.
Publicado: (2020)

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2022)

Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview
por: Guida, Andrea M., et al.
Publicado: (2022)

CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
por: Coppola, Alessandro, et al.
Publicado: (2021)

Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives
por: Coppola, Alessandro, et al.
Publicado: (2022)

Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck
por: Merlano, Marco, et al.
Publicado: (2007)

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
por: Tejani, Mohamedtaki A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_o0coi2ea1ig0ip3liep8u8ogv8